Portola sets IPO range

Portola Pharmaceuticals Inc. (South San Francisco, Calif.) amended its IPO and now plans to sell 6.9 million shares at $13-$16. At the $14.50 mid-point, Portola would raise $100.1 million and be valued at $469.2 million. Morgan Stanley; Credit Suisse; Cowen; William Blair; and Sanford C. Bernstein are underwriters. Portola filed to raise up to $115 million in the offering last month. ...